ROSELLA JORDAN: Open Payments
NPI 1710577960 · GRAYSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 9 payments from 5 companies in 2025. Trend: 2023 $339 · 2024 $583 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| ABBVIE INC. | 2 | $31 |
| Novo Nordisk Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: HETLIOZ, TRELEGY ELLIPTA, VRAYLAR, Ozempic, CAPLYTA.
Industry payments across KY — which companies pay providers there.
